Patent · US Active

Substituted 1,2,3,4-tetrahydroisoquinoline derivatives

US7763638B2 · kind B2 · utility

22Cited by

3References

6Claims

0Family size

Assignee

Actelion Pharmaceuticals Ltd. · CH

Inventors

Hamed Aissaoui · Allschwil, CH
Martine Clozel · Binningen, CH
Walter Fischli · Allschwil, CH
Ralf Koberstein · Bad Kötzting, DE
Thomas Weller · Binningen, CH

Key dates

Filing date	Feb 23, 2005
Grant date	Jul 27, 2010
Priority date	—
Expiry date	Jul 27, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel 1,2,3,4-tetrahydroisoquinoline derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and methods of treatment comprising administration of said compounds to a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.